JP2007526919A - 糖タンパク質ｇ２ペプチドを用いたｈｓｖ−２型特異的免疫検定 - Google Patents

糖タンパク質ｇ２ペプチドを用いたｈｓｖ−２型特異的免疫検定 Download PDF

Info

Publication number
JP2007526919A
JP2007526919A JP2007501755A JP2007501755A JP2007526919A JP 2007526919 A JP2007526919 A JP 2007526919A JP 2007501755 A JP2007501755 A JP 2007501755A JP 2007501755 A JP2007501755 A JP 2007501755A JP 2007526919 A JP2007526919 A JP 2007526919A
Authority
JP
Japan
Prior art keywords
peptide
heterologous
amino acid
carrier
linker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007501755A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007526919A5 (zh
Inventor
チェン，ペイリン
スー，ピーター
ユ，ハオ
ブレッカ，ラリー
エフ． コールマン，パトリック
Original Assignee
バイオ−ラッド ラボラトリーズ，インコーポレイティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイオ−ラッド ラボラトリーズ，インコーポレイティド filed Critical バイオ−ラッド ラボラトリーズ，インコーポレイティド
Publication of JP2007526919A publication Critical patent/JP2007526919A/ja
Publication of JP2007526919A5 publication Critical patent/JP2007526919A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/03—Herpetoviridae, e.g. pseudorabies virus
    • G01N2333/035—Herpes simplex virus I or II
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
JP2007501755A 2004-03-05 2004-03-05 糖タンパク質ｇ２ペプチドを用いたｈｓｖ−２型特異的免疫検定 Pending JP2007526919A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/006780 WO2005098051A2 (en) 2004-03-05 2004-03-05 Hsv-2 type-specific immunoassays using glycoprotein g2 peptides

Publications (2)

Publication Number Publication Date
JP2007526919A true JP2007526919A (ja) 2007-09-20
JP2007526919A5 JP2007526919A5 (zh) 2008-02-14

Family

ID=35125690

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007501755A Pending JP2007526919A (ja) 2004-03-05 2004-03-05 糖タンパク質ｇ２ペプチドを用いたｈｓｖ−２型特異的免疫検定

Country Status (6)

Country Link
EP (1) EP1725687A4 (zh)
JP (1) JP2007526919A (zh)
CN (1) CN101023187A (zh)
AU (1) AU2004318223B8 (zh)
CA (1) CA2558246C (zh)
WO (1) WO2005098051A2 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017502314A (ja) * 2013-12-18 2017-01-19 ボード・オブ・トラスティーズ、サザン・イリノイ・ユニバーシティ 患者が単純ヘルペスウイルス１型（ｈｓｖ−１）および／または２型（ｈｓｖ−２）に感染しているか否かを決定するための迅速で高感度な血清学的アッセイ

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101988600B1 (ko) 2011-06-29 2019-06-12 가부시키가이샤 엘에스아이 메디엔스 비특이 반응 억제제, 비특이 반응 억제 방법 및 키트
CN102798709B (zh) * 2012-08-17 2014-11-19 深圳市锦瑞电子有限公司 一种抗体偶联物及其方法
CN104804068B (zh) * 2014-01-26 2017-12-19 中国科学院青岛生物能源与过程研究所 一种多肽及其应用和将多肽共价连接到固相界面的方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003543A1 (en) * 1996-07-24 1998-01-29 Peptide Therapeutics Limited Identification of short peptide sequences representing epitopes of glycoprotein g of hsv-2 using a phage peptide display library
WO1999026067A1 (en) * 1997-11-18 1999-05-27 Bio-Rad Laboratories, Inc. Multiplex flow immunoassays with magnetic particles as solid phase
WO2003086308A2 (en) * 2002-04-11 2003-10-23 Corixa Corporation Compositions and methods for the diagnosis and treatment of herpes simplex virus infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2323360B (en) * 1997-01-14 1999-06-23 Medical Res Council Peptide structures and their use in diagnosis of herpes simplex virus type 2
US5919616A (en) * 1997-12-12 1999-07-06 Aurx, Inc. Serological assay for herpes
CA2329152A1 (en) * 1999-03-30 2000-10-05 Idexx Laboratories, Inc. Peptide vaccine for canine allergy

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003543A1 (en) * 1996-07-24 1998-01-29 Peptide Therapeutics Limited Identification of short peptide sequences representing epitopes of glycoprotein g of hsv-2 using a phage peptide display library
WO1999026067A1 (en) * 1997-11-18 1999-05-27 Bio-Rad Laboratories, Inc. Multiplex flow immunoassays with magnetic particles as solid phase
WO2003086308A2 (en) * 2002-04-11 2003-10-23 Corixa Corporation Compositions and methods for the diagnosis and treatment of herpes simplex virus infection

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017502314A (ja) * 2013-12-18 2017-01-19 ボード・オブ・トラスティーズ、サザン・イリノイ・ユニバーシティ 患者が単純ヘルペスウイルス１型（ｈｓｖ−１）および／または２型（ｈｓｖ−２）に感染しているか否かを決定するための迅速で高感度な血清学的アッセイ

Also Published As

Publication number Publication date
AU2004318223A1 (en) 2005-10-20
EP1725687A2 (en) 2006-11-29
AU2004318223B2 (en) 2009-05-21
WO2005098051A3 (en) 2006-03-23
CA2558246A1 (en) 2005-10-20
AU2004318223B8 (en) 2009-09-17
CN101023187A (zh) 2007-08-22
EP1725687A4 (en) 2008-09-24
WO2005098051A2 (en) 2005-10-20
CA2558246C (en) 2013-07-09

Similar Documents

Publication Publication Date Title
WO2008027942A2 (en) Combination hepatitis c virus antigen and antibody detection method
Gregorius et al. Hydrocoating: a new method for coupling biomolecules to solid phases
EP1328811B1 (en) Hcv mosaic antigen composition
CN111978377B (zh) Covid-19抗原、制备方法和应用
CA2840590C (en) Method for increasing specificity of diagnostic tests for autoimmune diseases
US7267940B2 (en) HSV-2 type-specific immunoassays using glycoprotein G2 peptides
CN108948153B (zh) 一种瓜氨酸修饰肽抗原组合及其应用
US8017342B2 (en) Solid phase immobilization of phospholipids and cofactor proteins via covalent attachment
AU2004318223B8 (en) HSV-2 type-specific immunoassays using glycoprotein G2 peptides
JP6808178B2 (ja) ヒトパルボウイルスｂ１９抗原および抗体の同時検出方法及びキット
US20140106381A1 (en) Method for the diagnosis of rheumatoid arthritis
JP5592277B2 (ja) エプスタイン−バーウイルス（ｅｂｖ）再活性化のインビトロ診断のためのｚｅｂｒａタンパク質由来合成ペプチドの使用
JP2000002707A (ja) Ｅｎｖ／ｇａｇポリペプチドマ―カ―を使用するネコ免疫不全ウイルス感染の診断
JPH09507025A (ja) ＨＥＶ ｏｒｆ−２に対するモノクローナル抗体及びそれらを使用する方法
CN108948174B (zh) 一种瓜氨酸修饰肽及其应用
CN108948173B (zh) 一种瓜氨酸修饰肽及其应用
AU756368B2 (en) Peptide structures and their use in diagnosis of herpes simplex virus type 2
JP3610736B2 (ja) Ｈｔｌｖ−ｉｉを特異的に認識するモノクローナル抗体及び該モノクローナル抗体を産生するハイブリドーマ
JPH08512406A (ja) 肝炎ｅ型ウイルス確認アッセイ及び試薬
JPH05307040A (ja) Ｃ型肝炎検査用試薬、および検査方法
MXPA99004991A (es) Deteccion de antigenos especificos para la inmunoglobulina clase m
DE19930933A1 (de) Verfahren zur Bestimmung von anti-LKM 1-Antikörpern

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071220

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100413

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100712

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100720

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101013

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110208